source
- Novartis ends $800M neuroscience partnership with BioArctic after 14 monthsNovartis signed an $800 million neuroscience partnership with BioArctic in August 2025, providing $30 million upfront to merge BioArctic’s BrainTransporter technology with a Novartis antibody targe…
- Abbott reports 30‑day success in Tectonic trial of SonicForce coronary IVL systemAbbott announced that its investigational SonicForce Coronary IVL system achieved positive 30‑day outcomes in the Tectonic trial involving patients with severely calcified coronary artery disease.…